[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@endpts Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::3460109487.png) @endpts Endpoints News

Endpoints News posts on X about sanofi, $67m, arms, $120m the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::3460109487/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3460109487/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX +177%
- X Months XXXXXXX +3.90%
- X Year XXXXXXX +329%

### Mentions: X [#](/creator/twitter::3460109487/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3460109487/c:line/m:posts_active.svg)

- X Week XX -XXXX%
- X Month XX +46%
- X Months XXX +33%
- X Year XXX +351%

### Followers: XXXXXX [#](/creator/twitter::3460109487/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3460109487/c:line/m:followers.svg)

- X Week XXXXXX +0.15%
- X Month XXXXXX +0.64%
- X Months XXXXXX +3.60%
- X Year XXXXXX +4.30%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::3460109487/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3460109487/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::3460109487/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX% [finance](/list/finance)  XXXX%

**Social topic influence**
[sanofi](/topic/sanofi) #30, [$67m](/topic/$67m) 2.63%, [arms](/topic/arms) 2.63%, [$120m](/topic/$120m) 2.63%, [white house](/topic/white-house) 2.63%, [$500m](/topic/$500m) 2.63%, [$8b](/topic/$8b) 2.63%, [acquisition](/topic/acquisition) 2.63%, [novartis](/topic/novartis) XXXX%

**Top accounts mentioned or mentioned by**
[@rlcscienceboss](/creator/undefined) [@andrewedunn](/creator/undefined) [@lukemaynard](/creator/undefined) [@medra_ai](/creator/undefined) [@dtrmweihe](/creator/undefined) [@maxonwifi](/creator/undefined) [@vijaypande](/creator/undefined) [@andrewe_dunn](/creator/undefined) [@leilei_wuu](/creator/undefined) [@beamtx](/creator/undefined) [@lux_capital](/creator/undefined) [@astellasus](/creator/undefined) [@eathopepray](/creator/undefined) [@dshaywitz](/creator/undefined) [@armstrongdrew](/creator/undefined) [@metricausa](/creator/undefined) [@polarisvc](/creator/undefined) [@ryanboehm](/creator/undefined) [@artsstocks](/creator/undefined) [@braincures](/creator/undefined)

**Top assets mentioned**
[Sanofi (SNY)](/topic/sanofi) [Novartis AG (NVS)](/topic/novartis)
### Top Social Posts [#](/creator/twitter::3460109487/posts)
---
Top posts by engagements in the last XX hours

"At #EASD25 Regeneron shared new data showing its anti-myostatin antibody may help preserve muscle in patients taking Wegovy for obesity"  
[X Link](https://x.com/endpts/status/1969115542398071129) [@endpts](/creator/x/endpts) 2025-09-19T19:05Z 30.6K followers, 1503 engagements


"Cartography raised $67M in part from Pfizer and Amgens VC arms to launch its first trial mapping a path for its T cell engager in colorectal cancer"  
[X Link](https://x.com/endpts/status/1973768088240931227) [@endpts](/creator/x/endpts) 2025-10-02T15:12Z 30.6K followers, 1166 engagements


"In Focus: Amgens David Reese traded his R&D role to lead its AI revolution. He calls it biotechs hinge moment and Endpoints @AndrewE_Dunn got an inside look"  
[X Link](https://x.com/endpts/status/1975970223623897584) [@endpts](/creator/x/endpts) 2025-10-08T17:03Z 30.6K followers, 1541 engagements


"Pelage Pharmaceuticals raised $120M to take its hair loss drug into Ph3 next year as backing from GV and ARCH boosts the tiny biotechs profile"  
[X Link](https://x.com/endpts/status/1978524271073767517) [@endpts](/creator/x/endpts) 2025-10-15T18:12Z 30.6K followers, 1131 engagements


"AstraZeneca expected to announce MFN deal with White House Friday evening"  
[X Link](https://x.com/endpts/status/1976697275045859469) [@endpts](/creator/x/endpts) 2025-10-10T17:12Z 30.6K followers, 1221 engagements


"In this weeks Peer Review: Boehringer Ingelheim names Vani Manja global obesity leader and ex-AbbVie Philip Kym steps in as Calicos head of drug discovery. Read the full job update:"  
[X Link](https://x.com/endpts/status/1979276445038870847) [@endpts](/creator/x/endpts) 2025-10-17T20:00Z 30.6K followers, 1077 engagements


"Sanofi and Orano Meds radiopharma AlphaMedix met both primary endpoints in Phase X for a rare type of cancer suggesting tumor shrinkage and prolonged benefits"  
[X Link](https://x.com/endpts/status/1975941322482815421) [@endpts](/creator/x/endpts) 2025-10-08T15:08Z 30.6K followers, 2110 engagements


"EVOQ Therapeutics signed a deal worth up to $500M with Sanofi to advance its Treg-targeting autoimmune tech"  
[X Link](https://x.com/endpts/status/1978833203323387957) [@endpts](/creator/x/endpts) 2025-10-16T14:39Z 30.6K followers, XXX engagements


"AlphaMedix a radiopharmaceutical developed by Sanofi and Orano shines at #ESMO25 after it announced positive mid-stage trial results for a rare cancer"  
[X Link](https://x.com/endpts/status/1980286430556430736) [@endpts](/creator/x/endpts) 2025-10-20T14:54Z 30.6K followers, 1038 engagements


"Genmab bets on its head and neck cancer pipeline with $8B acquisition of of Merus a Dutch biotech with a promising bispecific antibody"  
[X Link](https://x.com/endpts/status/1972662388441637208) [@endpts](/creator/x/endpts) 2025-09-29T13:58Z 30.6K followers, 1114 engagements


"Novartis is looking to expand Pluvicto to earlier prostate cancer but questions remain"  
[X Link](https://x.com/endpts/status/1980351156204568810) [@endpts](/creator/x/endpts) 2025-10-20T19:11Z 30.6K followers, 1150 engagements


"The "decade of ADCs" continues and they're expected to become the backbone of cancer care as AstraZeneca Kelun and Merck take the stage at #ESMO25"  
[X Link](https://x.com/endpts/status/1980607203582017557) [@endpts](/creator/x/endpts) 2025-10-21T12:08Z 30.6K followers, 1106 engagements